Clinical Results after High-Dose Intensity-Modulated Radiotherapy for High-Risk Prostate Cancer

Clinical Results after High-Dose Intensity-Modulated Radiotherapy for High-Risk Prostate Cancer

Purpose. Patients with high-risk prostate cancer (PC) can be treated with high-dose intensity-modulated radiotherapy (IMRT) and long-term androgen deprivation (AD). In this paper we report on (i) late toxicity and (ii) biochemical (bRFS) and clinical relapse-free survival (cRFS) of this combined tre...

Full description

Saved in:

Bibliographic Details
Main Authors:	Valérie Fonteyne, Nicolaas Lumen, Geert Villeirs, Piet Ost, Gert De Meerleer
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	Advances in Urology
Online Access:	http://dx.doi.org/10.1155/2012/368528
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
by: David Thomson, et al.
Published: (2012-01-01)

The prognostic value of boost dose in residual cervical lymph nodes in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy: a retrospective study
by: Mengting Xu, et al.
Published: (2025-02-01)

Impact of Number and Placement of High-dose Vertices on Equivalent Uniform Dose and Peak-to-valley Ratio for Lattice Radiotherapy
by: A. T. Bhagyalakshmi, et al.
Published: (2024-12-01)

A comparative analysis of toxicity and treatment outcomes of adaptive radiotherapy and intensity-modulated radiotherapy in cervical cancer
by: Xiaohan Liu, et al.
Published: (2025-01-01)

Urodynamic Evaluation after High-Intensity Focused Ultrasound for Patients with Prostate Cancer
by: Luigi Mearini, et al.
Published: (2014-01-01)

High Dose Radiotherapy to Automated Implantable Cardioverter-Defibrillator: A Case Report and Review of the Literature
by: Inaya Ahmed, et al.
Published: (2014-01-01)

6 Survival results of PSMA/PET-based salvage radiotherapy for recurrent prostate cancer
by: N. Grivas, et al.
Published: (2025-01-01)

Associations of dose to the urethra and long-term patient-reported outcomes after radiotherapy with EBRT and HDR brachytherapy boost for prostate cancer
by: Lars Haack, et al.
Published: (2025-03-01)

Ultra-high dose rate (FLASH) radiotherapy: Revolutionizing tumor targeting and microenvironmental dynamics in cancer treatment
by: Zhiming Wang, et al.
Published: (2024-12-01)

No impairment of quality of life after radiotherapy for prostate cancer
by: Maria M. Meier, et al.
Published: (2024-12-01)

Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey
by: Jennifer Le Guévelou, et al.
Published: (2025-03-01)

Dosimetric and Radiobiological Impact of Patient Setup Errors in Intensity-modulated Radiotherapy for Esophageal Cancer
by: Jia-Huan Cai MS, et al.
Published: (2025-01-01)

Dose-volume parameter evaluation of a sub-fractionation workflow for adaptive radiotherapy of prostate cancer patients on a 1.5 T magnetic resonance imaging radiotherapy system
by: Georgios Tsekas, et al.
Published: (2025-01-01)

Added value of non-rigid image registration for intrafraction dose accumulation in magnetic resonance imaging-guided prostate radiotherapy
by: Georgios Tsekas, et al.
Published: (2025-01-01)

New rectum dose surface mapping methodology to identify rectal subregions associated with toxicities following prostate cancer radiotherapy
by: Artemis Bouzaki, et al.
Published: (2025-01-01)

High-Intensity Focused Ultrasound for Prostate Cancer: Long-Term Followup and Complications Rate
by: Umberto Maestroni, et al.
Published: (2012-01-01)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
by: L. Chinsoo Cho, et al.
Published: (2013-01-01)

High-Dose Antibiotics in Intensive Care: A Review of Their Role in Combatting and Contributing to Antimicrobial Resistance
by: Galo G. Farfán-Cano, et al.
Published: (2024-12-01)

A Novel Split-Course High-Dose Palliative Radiotherapy Regimen for Locally Advanced Sinonasal Cancer: A Case Report
by: Saif Aljabab, et al.
Published: (2024-01-01)

Radiotherapy for Oligometastases and Oligo-Recurrence of Bone in Prostate Cancer
by: Ken-ichi Tabata, et al.
Published: (2012-01-01)

MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer
by: Andrea Gaetano Allegra MD, et al.
Published: (2025-01-01)

Thyroid Dysfunction After Intensity-Modulated Radiotherapy and PD⁃1 Inhibitor Treatment for Locally Advanced Nasopharyngeal Carcinoma
by: Shang K, et al.
Published: (2025-01-01)

The initial results of MRI-TRUS fusion prostate biopsy in high volume tertiary center
by: Smrkolj Tomaz, et al.
Published: (2024-11-01)

Accuracy-dependent dose-constraints and dose-based safety margins for organs-at-risk in radiotherapy
by: Joep C. Stroom, et al.
Published: (2025-01-01)

Intensity-Modulated Radiotherapy for a Rendu-Osler-Weber Disease Patient with Recurrent Severe Epistaxis: A Case Report
by: Maximilian Niyazi, et al.
Published: (2010-01-01)

Optimizing the dose-averaged linear energy transfer for the dominant intraprostatic lesions in high-risk localized prostate cancer patients
by: Bo Zhao, et al.
Published: (2025-01-01)

High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis
by: Fouad Aoun, et al.
Published: (2015-01-01)

High-Intensity Focused Ultrasound (HIFU) Focal Therapy for Localized Prostate Cancer with MRI-US Fusion Platform
by: Chi-Hang Yee, et al.
Published: (2021-01-01)

Survival in Ecuadorian Patients with Prostate Cancer Clinically Treated with Radiotherapy and Chemotherapy
by: Alberto Sánchez Garrido, et al.
Published: (2024-01-01)

Effectiveness, toxicity and impact on quality of life of high-dose-rate brachytherapy delivered in two fractions as monotherapy in patients with prostate cancer
by: Johan Staby Olsén, et al.
Published: (2025-03-01)

High and low dose radiotherapy combined with ICIs for MSS colorectal cancer patients with liver metastases: a phase I study (HaRyPOT)
by: Yuxuan Ding, et al.
Published: (2025-02-01)

Langerhans Cell Histiocytosis of the Cranial Base: Is Low-Dose Radiotherapy Effective?
by: Andreas Meyer, et al.
Published: (2012-01-01)

High-Intensity Focused Ultrasound Ablation for Primary or Salvage Prostate Cancer Therapy: Initial Outcomes in the Veteran Healthcare Setting
by: Sagar Patel, et al.
Published: (2024-12-01)

Systematic Review of the Relationship between Acute and Late Gastrointestinal Toxicity after Radiotherapy for Prostate Cancer
by: Matthew Sean Peach, et al.
Published: (2015-01-01)

Out-of-field dose assessment for pencil beam scanning proton radiotherapy versus photon radiotherapy for breast cancer in pregnant women
by: Menke Weessies, et al.
Published: (2025-01-01)

Dose-dependent effects of apple pectin on alleviating high fat-induced obesity modulated by gut microbiota and SCFAs
by: Yuanyuan Zhao, et al.
Published: (2022-01-01)

Comparison of outcome and toxicity of postoperative intensity‐modulated radiation therapy with two‐dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk
by: Jianyang Wang, et al.
Published: (2019-03-01)

Development of Novel Nomograms to Predict 5- and 7-Year Biochemical-Recurrence-Free Survival in High-Risk Prostate Cancer Patients After Carbon-Ion Radiotherapy and Androgen Deprivation Therapy
by: Takanobu Utsumi, et al.
Published: (2025-01-01)

Prognostic value of intraductal carcinoma subtypes and postoperative radiotherapy for localized prostate cancer
by: Fang Cao, et al.
Published: (2025-01-01)

A Dose-Response Relationship to Radiotherapy for Cutaneous Lesions of Langerhans Cell Histiocytosis
by: Mark K. Farrugia, et al.
Published: (2021-01-01)